The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights. The partners will abstract data from thousands of medical charts of patients enrolled in the American Cancer Society’s research studies, with the ultimate goal of shortening research timelines. The post…
AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotec’s allogeneic cell therapies are made by the in vivo reprogramming of a patient’s immune cells. The post AstraZeneca Aims to Make Cell…
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isn’t Intelligence in Healthcare appeared first on MedCity News.
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented. The post Better Science, Better Medicine: How Clinical Research Advances Women’s Health appeared first on MedCity News.
Congress passed a continuing resolution last week that extended expiring Medicare telehealth flexibilities through the next six months. Telehealth CEOs view the passing of the resolution as a short-term win, but they think there is still more work to do to ensure Americans have permanent access to virtual care services in the future. The post…
Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability. The post Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M appeared first on MedCity News.
The lessons learned and shared by some of the industry’s leaders are exciting, and some clear opportunities are developing. But under the surface, this year, there is something else, and I’m not sure it’s getting enough attention: anxiety. The post Cautious Pessimism – What Isn’t Being Talked About, And What It Means For Healthcare appeared…
Workforce mental health isn’t just an HR issue, it’s also a business imperative. Companies that integrate evidence-based solutions into their benefits reduce medical costs, improve productivity, and retain top talent. The post The High Price of Treatment Resistant Depression for Employers appeared first on MedCity News.
Breast cancer survivor Kate Dilligan is the CEO of Cooler Heads, a company that sells a portable and self-administered scalp cooling device. The system helps chemotherapy patients retain their hair, as therefore their self-esteem and privacy. The post ‘It’s Not About Beauty, It’s About Privacy’: How One Cancer Survivor Is Changing Chemo Care appeared first…
MeiraGTx’s gene therapy for Parkinson’s disease will enter Phase 3 testing under a new joint venture the biotech is forming with Hologen, a generative AI startup. The joint venture has up to $230 million in committed capital; MeiraGTx gets additional cash for its pipeline. The post Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI…